Epilepsy is defined as a diverse set of neurological disorders characterized by seizures. These seizures occur due to abnormal electrical activity in the brain. Factors that may lead to epilepsy include, but are not limited to, brain trauma, gene mutations, strokes, brain cancer, and extensive drug and alcohol use. Seizures occur due to a large release of glutamate, which causes a spread of excitation throughout the brain, which propagates the electrical signal and can lead to neuronal death. Refractory localization-related epilepsy affects only a small region of the brain, often the temporal lobes or hippocampi, and does not respond to drug treatments. People who have refractory localization-related epilepsy typically retain consciousness during their seizures. Localization-related seizures are often precursors to larger seizures, where the abnormal electrical activity spreads to a larger area of the brain. Because of this, they are often known as an aura. About 50 million people have epilepsy, with 80% of that population located in developing countries. It is possible to control epilepsy with medicine, but many cases, especially refractory epilepsy, may require surgery in order to relieve symptoms.
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Refractory Localization-related Epilepsy below!
For more information on how to use Laverne, please read the How to Guide.
We have 608 products for the study of Refractory Localization-related Epilepsy that can be applied to Flow Cytometry, Western Blot, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.